Teratogenic effects of vaginal boric acid treatment during pregnancy.
Acs
N
N
Second Department of Obstetrics and Gynecology, Semmelweis University, School of Medicine, and Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary.
Bánhidy
F
F
Puhó
E
E
Czeizel
A E
AE
D000014:Abnormalities, Drug-Induced / Q000145:classification / Q000209:etiology*; D001888:Boric Acids / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D016896:Treatment Outcome
D001888:Boric Acids